Abstract. This study aimed to develop an antiserum specific to follicle stimulating hormone (FSH), for a wide range of species, free from cross-reactivity against luteinizing hormone. An antiserum against recombinant porcine FSH (rec-pFSH) expressed in insect cells was raised in a rabbit and its specificity was characterized by time-resolved fluoroimmunoassay (TR-FIA) and immunohistochemistry. The titer of the anti-rec-pFSH antiserum was about 1:5,000 for use in TR-FIA. The inhibition curve of TR-FIA with rec-pFSH paralleled that of pituitary-derived FSH, indicating that the antigenicities of the two FSH preparations do not differ significantly. The anti-rec-pFSH antiserum showed low reactivities with FSHs prepared from sheep and rat, suggesting it was species-and hormone-specific, contrary to our intention. The TR-FIA showed that this antiserum did not react with pituitary extracts from mammals other than the pig. However, immunohistochemistry demonstrated that this antiserum reacted with the specific cells not only of the porcine anterior pituitary but also of the cow, goat, and horse. The antiserum also immunostained pituitary cells of the cow, goat and horse. Therefore, this anti-rec-pFSH antiserum will be of limited use in studies involving competitive immunoreactions due to its species-specific reactivity, but it should be useful for non-competitive techniques, such as immunohistochemistry.
FSH remain to be elucidated. One of the major factors hampering the elucidation of its functions h a s b e e n t h e l a c k o f p u r e F S H f r e e f r o m contamination with LH. Recentrly, however, genetic engineering techniques have enabled FSH [1] [2] [3] [4] in a pure form without LH contamination to be prepared. A specific antiserum developed by recombinant FSH free from cross-reactivity with LH is of value for immunohistochemistry and western blot analysis as well as for competitive immunoassay.
Recently, we used a baculovirus expression vector to express recombinant porcine follicle stimulating hormone (rec-pFSH) in insect cells and obtained an almost pure form of rec-pFSH [4] . The preparation had a molecular weight slightly different from that of the pituitary-derived pFSH, owing to incomplete glycosylation, but its biological activities in vitro and in vivo, i.e., stimulation of progesterone secretion by porcine granulosa cells and germinal vesicle break down of porcine oocytes, respectively, were the same [4] [5] [6] . In this study, we established an antiserum against rec-pFSH and characterized its specificity in order to determine whether it could be used for c o m p e t i t i v e i m m u n o a s s a y s a n d immunohistochemical analysis of rec-FSH of the pig and other domestic animal species.
Materials and Methods

Rec-pFSH and pituitary hormones
Rec-pFSH was prepared as described previously [4] . Briefly, rec-pFSH was expressed in insect cells infected with a virus constructed from a dual expression vector with α-and β-subunit cDNA each in a distinct promoter, pAcUW3αβ. Rec-pFSH was recovered from the culture media by serial column chromatography with S-Sepharose and ConA resins (Pharmacia LKB, Uppsala, Sweden).
The pituitary hormones used, pFSH (NIDDK pFSH I-1), pLH (USDA-pLH B-1), rat (r)FSH (NIDDK rFSH I-8), rLH (NIDDK rLH I-6), ovine (o)FSH (NIDDK oFSH I-1), oLH (NIDDK oLH I-3) and bovine (b)TSH (NIDDK bTSH-I-8), were provided by the National Pituitary Agency.
Preparation of pituitary extracts
Pituitary protein extracts were prepared as described by Ishikawa et al. [7] . A protein assay kit (Bio-Rad Laboratories, Richmond, CA, USA) was employed to measure the protein concentration of pituitary extracts using bovine serum albumin as a standard, followed by dilution at 10 mg/ml.
Antiserum
The lymph node immunization method of Goudie et al. [8] , which only requires a very small quantity of protein, was used for immunization against rec-pFSH. First, normal saline (200 µl) containing 2% (v/v) Evans blue dye was injected into each of the popliteal lymph-nodes (both legs) of a 2-kg female rabbit to visualize a portion of the node and 1 h later, rec-pFSH (100 µg) emulsified in Freund's complete adjuvant was injected into the lymph node. Four weeks later, the rabbit received rec-pFSH (100 µg) by intradermal, multi-site injection in the back. This was repeated three times every three weeks. Ten days after the final injection, the rabbit was bled from the common carotid artery, and the serum was separated by centrifugation and stored at -70 C until required for use.
Time-resolved fluoroimmunoassay (TR-FIA)s
TR-FIA of FSH was performed as described in our previous paper [9] . Porcine FSH (NIH I-1, 20 µg in 20 ml 500 mM sodium carbonate-bicarbonate buffer, pH 9.8) was labeled with a 30-fold molar excess of Eu-labeling reagent (Eu-chelate of N1-(pisothiocyanatobenzyl)-diethylenetriamine-N1, N2, N 3 , N 3 -tetraacetic acid; Pharmacia, Uppsala, Sweden) for 4 h at room temperature and the Eulabeled FSH was separated by chromatography using a Sephacryl S-100 HR (1 × 18 cm) column (Pharmacia). Ninety-six-well titer plates were immobilized with HCl-treated anti-rabbit IgG, incubated with 50 µl standard FSH or sample and 100 µl antiserum in assay buffer (0.5% (w/v) bovine serum albumin, 50 mM Tris-HCl, pH 7.75, Pharmacia) at room temperature with shaking for 1.5 h. Then, 100 µl Eu-labeled FSH (20 ng/ml) was added to each well. The plates were incubated at room temperature for a further 3.5 h with shaking, followed by washing with 0.9% NaCl containing 0.02% (v/v) Tween 20 and 0.05% (w/v) NaN3. Two-hundred microliters of enhancement solution (Pharmacia) was added to each well to enhance the Eu-fluorescence. After mixing, the fluorescence intensity of Eu was measured with a time-resolved fluorometer (Arcus 1230, Pharmacia).
Histochemistry
Anterior pituitaries of various mammals were fixed by immersing them in Bouin-Hollande solution for 2 days. They were dehydrated, embedded in paraplast. Sections of 5-µm-thickness were cut, mounted on gelatin-coated slides and incubated in 500 mM sodium metaperiodate for 30 min to inhibit endogenous peroxidase activity. The following procedures were carried out at room temperature. After rinsing with distilled water and phosphate-buffered saline, the sections were treated with normal horse serum, incubated with the rabbit anti-FSH antiserum (1:2,000) followed by goat anti-rabbit immunoglobulin (1:5,000) and then rea c te d w i th per ox id a se c on j u ga t ed -a n tiperoxidase immuno-complex (1:
T o v e r i f y t h e s p e c i f i c i t y o f a n t i s e r a , neutralization of anti-rec-pFSH antiserum was performed with rec-pFSH or pLH (both 10 -7 , 10 -8 10 -9 and 10 -10 M) overnight at room temperature, followed by centrifugation to remove the resulting precipitates.
Results and Discussion
It has been difficult to raise anti-FSH antisera with high titers. We have tried several methods to prepare anti-FSH antisera, including immunization of the lymph nodes of rabbits using a TiterMax (CytRx Corporation, Atlanta, GA), which was developed to produce high-titer antisera [10, 11] . However, the anti-FSH titer resulting from this immunization procedure was no higher than 1:2,000 (data not shown), which is not high enough for use in in vitro experiments. We eventually obtained a high-titer antiserum by a conventional method of lymph node immunization using Freund's complete adjuvant followed by four intradermal, booster injections at three-week intervals. Fig. 1 shows the competitive binding curves of the TR-FIA. The binding of the Eu-labeled recpFSH to the anti-rec-pFSH was inhibited by the addition of unlabeled rec-pFSH in a dosedependent manner. When pituitary-derived pFSH preparation was added instead of the recombinant hormone, a similar inhibition curve was obtained.
These two curves were almost parallel, indicating that the antigenicitiy of the rec-pFSH does not differ significantly from the pituitary-derived pFSH as far as this antibody is concerned. These two curves almost overlie each other, indicating that the sensitivity of the present TR-FIA is almost the same for rec-pFSH and pFSH. These results suggest that the anti-rec-pFSH antiserum we raised is suitable for use in the assay of in vitro samples.
In order to determine whether this antiserum can be used for the quantitative immunoassay of FSH from other species, TR-FIA of rFSH and oFSH was performed. The competitive binding curves illustrated in Fig. 2 show that these FSHs did not compete as efficiently for binding to the antiserum as rec-pFSH, although oFSH showed higher reactivity than rFSH. Therefore, this anti-rec-pFSH antiserum may not be suitable for quantitative analysis of FSH from species other than the pig.
TR-FIA of protein extracts prepared from the pituitaries of the pig, cow, goat and horse was also carried out. As shown in Fig. 4 , the anti-rec-pFSH antiserum only reacted with the porcine pituitary extract. The results supported those of TR-FIA of oFSH and rFSH. Therefore, the usage of this antirec-pFSH antiserum for competitive immunoassays may be restricted to the analysis of porcine FSH, because the affinity of this antiserum for FSH from other species is too low for quantitative analysis.
Several pituitary hormones were examined to The concentration of recpFSH was measured prior to the assay and rec-pFSH, pFSH and pLH, diluted to the concentrations indicated, were assayed by TR-FIA using Eu-labeled rec-pFSH as a tracer, as described in Materials and Methods.
determine the specificity of their immunoreactivity with the anti-rec-pFSH antiserum, as the related pituitary glycoprotein hormones LH and TSH also possess the α -subunit of FSH. The results illustrated in Fig. 3 indicated that pLH, rLH, oLH and bTSH did not react with the anti-rec-pFSH antiserum, indicating the high hormone specificity of this antiserum.
The results of species specificity described above indicate that although anti-rec-pFSH is available for the competitive binding immunoassay, its use is limited to porcine FSH assay, contrary to our intention. A possible explanation for this is that FSH of species other than the pig cannot compete significantly with labeled rec-pFSH, because the anti-rec-pFSH antiserum has a very low affinity to them. However, this antiserum for FSH will be u s e f u l f o r o t h e r a p p l i c a t i o n s , s u c h a s immunohistochemistry, since low-aff inity antibodies would bind to the antigen significantly if i t w a s u s e d f o r n o n -c o m p e t i t i v e b i n d i n g applications such as in immunohistochemistry, as described by Wakabayashi and Tanaka [12] . Therefore, we carried out immunohistochemistry using our anti-rec-pFSH antiserum.
The anti-rec-pFSH antiserum definitely reacted with porcine gonadotropes (Fig. 5) . Absorption of the antiserum with rec-pFSH (10 -9 M) prior to immunohistochemistry resulted in abolition of the r e a c t i o n ( F i g . 5 C ) , w h e r e a s p o s i t i v e l y immunostained cells remained after adsorption with pLH at the same concentration (Fig. 5B) , although the intensity of the immunostaining was somewhat decreased. This decrease could be due to contamination of the LH preparation with FSH (TR-FIA showed that about 0.17% of LH reacted with the anti-rec-pFSH antiserum, shown in Fig. 3 ) or cross-reactivity of the antiserum with LH. We could not ascertain whether either or both of these proposed mechanisms apply, because there is no pure LH preparation that is guaranteed FSH-free available at present.
We subjected the pituitary glands from four animal species to immunohistochemical study of FSH (Fig. 6) . The porcine anterior pituitary was immunostained with the anti-rec-pFSH antibody at a dilution of 1:2000, whereas a dilution of 1:1000 was required to stain the pituitaries of the cow, horse and goat, as the reactivities of these tissues with the antiserum were slightly lower than that of the porcine pituitary. Immunoreactive cells were Immunohistochemistry using the anti-rec-pFSH antiserum. (A) The antiserum was used at dilution of 1:2,500 and immunohistochemistry was carried out after the antiserum had been treated with pLH (B) and rec-pFSH (C) (both 10 -9 M), × 40.
